Advertisement
Screener

NORTHWEST BIOTHERAPEUTICS INC (NWBO) Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

1.9 / 5 stars · 39/103 Roast Me

NORTHWEST BIOTHERAPEUTICS INC Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)

NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of -$21.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Other Income

us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2026-08-14

  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2026-06-30 was -$6.50M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2026-03-31 was -$14.85M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2025-12-31 was -$20.70M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2025-09-30 was $3.46M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2025 was -$25.07M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2024 was -$8.10M.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2023 was -$1.54M, a 105.99% decline from fiscal 2022.
  • NORTHWEST BIOTHERAPEUTICS INC fair value, liability, recurring basis, still held, unrealized gain (loss) for fiscal 2022 was $25.79M.
Period endFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 monthFair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month
2026-06-30-$6.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$21.35M
10-Q · filed 2026-08-14
-$42.05M
derived: sum of 3 quarters · filed 2026-08-14
-$38.59M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$14.85M
10-Q · filed 2026-05-15
-$35.55M
derived: sum of 2 quarters · filed 2026-05-15
-$32.09M
derived: sum of 3 quarters · filed 2026-05-15
-$34.97M
derived: sum of 4 quarters · filed 2026-05-15
2025-12-31-$20.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
-$17.24M
derived: sum of 2 quarters · filed 2026-04-15
-$20.11M
derived: sum of 3 quarters · filed 2026-04-15
-$25.07M
10-K · filed 2026-04-15
2025-09-30$3.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$589.00K
derived: sum of 2 quarters · filed 2025-11-14
-$4.37M
10-Q · filed 2025-11-14
-$6.87M
derived: sum of 4 quarters · filed 2026-04-15
2025-06-30-$2.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$7.83M
10-Q · filed 2025-08-14
-$10.33M
derived: sum of 3 quarters · filed 2026-04-15
-$11.90M
derived: sum of 4 quarters · filed 2026-04-15
2025-03-31-$4.95M
10-Q · filed 2025-05-15
-$7.46M
derived: sum of 2 quarters · filed 2026-04-15
-$9.03M
derived: sum of 3 quarters · filed 2026-04-15
-$11.26M
derived: sum of 4 quarters · filed 2026-04-15
2024-12-31-$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
-$4.07M
derived: sum of 2 quarters · filed 2026-04-15
-$6.31M
derived: sum of 3 quarters · filed 2026-04-15
-$8.10M
10-K · filed 2026-04-15
2024-09-30-$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$3.80M
derived: sum of 2 quarters · filed 2024-11-12
-$5.59M
10-Q · filed 2024-11-12
-$2.73M
derived: sum of 4 quarters · filed 2025-03-31
2024-06-30-$2.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$4.02M
10-Q · filed 2024-08-09
-$1.16M
derived: sum of 3 quarters · filed 2025-03-31
-$1.53M
derived: sum of 4 quarters · filed 2025-03-31
2024-03-31-$1.79M
10-Q · filed 2024-05-10
$1.07M
derived: sum of 2 quarters · filed 2025-03-31
$700.00K
derived: sum of 3 quarters · filed 2025-03-31
$494.00K
derived: sum of 4 quarters · filed 2025-03-31
2023-12-31$2.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$2.49M
derived: sum of 2 quarters · filed 2025-03-31
$2.28M
derived: sum of 3 quarters · filed 2025-03-31
-$1.54M
10-K · filed 2025-03-31
2023-09-30-$375.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$581.00K
derived: sum of 2 quarters · filed 2023-11-09
-$4.41M
10-Q · filed 2023-11-09
$5.50M
derived: sum of 4 quarters · filed 2024-03-05
2023-06-30-$206.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$4.03M
10-Q · filed 2023-08-09
$5.87M
derived: sum of 3 quarters · filed 2024-03-05
$18.04M
derived: sum of 4 quarters · filed 2024-03-05
2023-03-31-$3.83M
10-Q · filed 2023-05-10
$6.08M
derived: sum of 2 quarters · filed 2024-03-05
$18.25M
derived: sum of 3 quarters · filed 2024-03-05
$22.50M
derived: sum of 4 quarters · filed 2024-03-05
2022-12-31$9.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
$22.07M
derived: sum of 2 quarters · filed 2024-03-05
$26.33M
derived: sum of 3 quarters · filed 2024-03-05
$25.79M
10-K · filed 2024-03-05
2022-09-30$12.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$16.42M
derived: sum of 2 quarters · filed 2022-11-09
$15.88M
10-Q · filed 2022-11-09
-$129.93M
derived: sum of 4 quarters · filed 2023-02-28
2022-06-30$4.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$3.71M
10-Q · filed 2022-08-09
-$142.10M
derived: sum of 3 quarters · filed 2023-02-28
-$200.57M
derived: sum of 4 quarters · filed 2023-02-28
2022-03-31-$540.00K
10-Q · filed 2022-05-10
-$146.35M
derived: sum of 2 quarters · filed 2023-02-28
-$204.82M
derived: sum of 3 quarters · filed 2023-02-28
-$222.32M
derived: sum of 4 quarters · filed 2023-02-28
2021-12-31-$145.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$204.28M
derived: sum of 2 quarters · filed 2023-02-28
-$221.78M
derived: sum of 3 quarters · filed 2023-02-28
-$239.35M
10-K · filed 2023-02-28
2021-09-30-$58.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$75.97M
derived: sum of 2 quarters · filed 2021-11-15
-$93.54M
10-Q · filed 2021-11-15
2021-06-30-$17.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$35.06M
10-Q · filed 2021-08-16
2021-03-31-$17.56M
10-Q · filed 2021-05-17
2020-12-31$435.35M
10-K · filed 2022-03-01
2019-12-31-$11.83M
10-K · filed 2021-03-31
2018-12-31$917.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$23.44M
derived: sum of 2 quarters · filed 2020-03-16
-$29.75M
derived: sum of 3 quarters · filed 2020-03-16
-$18.30M
10-K · filed 2020-03-16
2018-09-30-$24.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-16
-$30.67M
derived: sum of 2 quarters · filed 2018-11-16
-$19.22M
10-Q · filed 2018-11-16
-$13.68M
derived: sum of 4 quarters · filed 2019-04-02
2018-06-30-$6.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$5.14M
10-Q · filed 2018-08-14
$10.68M
derived: sum of 3 quarters · filed 2019-04-02
$15.61M
derived: sum of 4 quarters · filed 2019-04-02
2018-03-31$11.45M
10-Q · filed 2018-05-16
$16.99M
derived: sum of 2 quarters · filed 2019-04-02
$21.93M
derived: sum of 3 quarters · filed 2019-04-02
$15.47M
derived: sum of 4 quarters · filed 2019-04-02
2017-12-31$5.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02
$10.47M
derived: sum of 2 quarters · filed 2019-04-02
$4.02M
derived: sum of 3 quarters · filed 2019-04-02
$2.58M
10-K · filed 2019-04-02
2017-09-30$4.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20
-$1.52M
derived: sum of 2 quarters · filed 2017-11-20
-$2.96M
10-Q · filed 2017-11-20
2017-06-30-$6.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21
-$7.90M
10-Q · filed 2017-08-21
2017-03-31-$1.44M
10-Q · filed 2017-05-15
2016-12-31-$17.89M
10-K · filed 2018-04-17
2015-12-31-$15.68M
10-K · filed 2017-04-17
2014-09-30-$14.00M
10-Q · filed 2014-11-19
-$18.69M
derived: sum of 2 quarters · filed 2014-11-19
-$1.70M
derived: sum of 3 quarters · filed 2014-11-19
2014-06-30-$4.68M
10-Q · filed 2014-11-19
$12.30M
derived: sum of 2 quarters · filed 2014-11-19
2014-03-31$16.98M
10-Q · filed 2014-11-19